In vitro–in vivo correlation of drug release profiles from medicated contact lenses using an in vitro eye blink model

Author:

Pereira-da-Mota Ana F.ORCID,Vivero-Lopez MariaORCID,Garg PiyushORCID,Phan Chau-MinhORCID,Concheiro AngelORCID,Jones LyndonORCID,Alvarez-Lorenzo CarmenORCID

Abstract

AbstractThere is still a paucity of information on how in vitro release profiles from drug-loaded contact lenses (CLs) recorded in 3D printed eye models correlate with in vivo profiles. This work aims to evaluate the release profiles of two drug-loaded CLs in a 3D in vitro eye blink model and compare the obtained results with the release in a vial and the drug levels in tear fluid previously obtained from an animal in vivo study. In vitro release in the eye model was tested at two different flow rates (5 and 10 µL/min) and a blink speed of 1 blink/10 s. Model CLs were loaded with two different drugs, hydrophilic pravastatin and hydrophobic resveratrol. The release of both drugs was more sustained and lower in the 3D eye model compared to the in vitro release in vials. Interestingly, both drugs presented similar release patterns in the eye model and in vivo, although the total amount of drugs released in the eye model was significantly lower, especially for resveratrol. Strong correlations between percentages of pravastatin released in the eye model and in vivo were found. These findings suggest that the current 3D printed eye blink model could be a useful tool to measure the release of ophthalmic drugs from medicated CLs. Nevertheless, physiological parameters such as the composition of the tear fluid and eyeball surface, tear flow rates, and temperature should be optimized in further studies. Graphical abstract

Funder

H2020 Marie Skłodowska-Curie Actions

Ministerio de Ciencia e Innovación

Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia

Innovation and Technology Commission - Hong Kong

Natural Sciences and Engineering Research Council of Canada

European Regional Development Fund

Universidade de Santiago de Compostela

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Reference44 articles.

1. Wichterle O. U.S. Patents. 3,660,545; 3,408,429; 3,496,254; 3,499,862.

2. https://www.jjvision.com/press-release/johnson-johnson-vision-care-receives-fda-approval-acuvuer-theravisiontm-ketotifen. Accessed Oct 2022.

3. Lanier OL, Christopher KG, Macoon RM, Yu Y, Sekar P, Chauhan A. Commercialization challenges for drug eluting contact lenses. Expert Opin Drug Deliv. 2020;17:1133–49. https://doi.org/10.1080/17425247.2020.1787983.

4. https://www.reviewofcontactlenses.com/article/material-gains-50-years-of-the-soft-contact-lens. Accessed Oct 2022.

5. Jones L, Hui A, Phan CM, Read ML, Azar D, Buch J, Ciolino JB, Naroo SA, Pall B, Romond K, Sankaridurg P, Schnider CM, Terry L, Willcox M. CLEAR - contact lens technologies of the future. Cont Lens Anterior Eye. 2021;44:398–430. https://doi.org/10.1016/j.clae.2021.02.007.

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3